Germany
# |
Name |
Free Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 5.15 B
|
Dec. 31, 2023 | USD 116.36 | -0.45% |
|
Germany |
|
2 |
USD 2.61 B
|
Dec. 31, 2023 | USD 20.20 | -1.60% |
|
Germany |
|
3 |
USD 1.94 B
|
Dec. 31, 2023 | USD 145.16 | 0.75% |
|
Germany |
|
4 |
USD 336.87 M
|
Dec. 31, 2023 | USD 49.86 | 0.81% |
|
Germany |
|
5 |
USD 23.31 M
|
Dec. 31, 2023 | USD 48.95 | 1.72% |
|
Germany |
|
6 |
USD 13.98 M
|
Dec. 31, 2023 | USD 18.55 | -3.93% |
|
Germany |
|
7 |
USD 5.59 M
|
Dec. 31, 2023 | USD 4.18 | 0.60% |
|
Germany |
|
8 |
USD 2.21 M
|
Dec. 31, 2023 | USD 29.11 | 3.16% |
|
Germany |
|
9 |
USD -3.25 M
|
Dec. 31, 2023 | USD 4.96 | -2.24% |
|
Germany |
|
10 |
USD -6.12 M
|
Dec. 31, 2023 | USD 21.54 | 1.09% |
|
Germany |
|
11 |
USD -7.25 M
|
Sept. 30, 2023 | USD 3.68 | 1.46% |
|
Germany |
|
12 |
USD -11.33 M
|
Dec. 31, 2023 | USD 1.49 | -0.76% |
|
Germany |
|
13 |
USD -14.05 M
|
Dec. 31, 2023 | USD 5.97 | -4.48% |
|
Germany |
|
14 |
USD -17.42 M
|
Dec. 31, 2023 | USD 1.09 | 3.54% |
|
Germany |
|
15 |
USD -23.84 M
|
Dec. 31, 2023 | USD 5.29 | 13.28% |
|
Germany |
|
16 |
USD -24.34 M
|
Dec. 31, 2023 | USD 2.11 | 3.12% |
|
Germany |
|
17 |
USD -33.77 M
|
Dec. 31, 2023 | USD 60.50 | -1.24% |
|
Germany |
|
18 |
USD -37.70 M
|
Nov. 30, 2023 | USD 2.61 | 0.60% |
|
Germany |
|
19 |
USD -39.85 M
|
Dec. 31, 2023 | USD 42.87 | 0.60% |
|
Germany |
|
20 |
USD -41.83 M
|
Dec. 31, 2023 | USD 2.34 | NA |
|
Germany |
|
21 |
USD -84.71 M
|
Dec. 31, 2023 | USD 1.33 | -6.34% |
|
Germany |
|
22 |
USD -125.83 M
|
Dec. 31, 2023 | USD 1.07 | -4.46% |
|
Germany |
|
23 |
USD -198.19 M
|
Dec. 31, 2023 | USD 8.09 | -2.02% |
|
Germany |
|
24 |
USD -356.61 M
|
Dec. 31, 2023 | USD 3.95 | -0.95% |
|
Germany |
The Biotechnology company in Germany with the highest Free Cash Flow is BioNTech SE (Frankfurt Stock Exchange: 22UA.F) at USD 5.15 B.
The Biotechnology company in Germany with the lowest Free Cash Flow is CureVac N.V. (Frankfurt Stock Exchange: 5CV.F) at USD -356.61 M.
The top 10 Biotechnology companies in Germany by Free Cash Flow are BioNTech SE, Bayer Aktiengesellschaft, MERCK Kommanditgesellschaft auf Aktien, GEA Group Aktiengesellschaft, Eckert & Ziegler Strahlen- und Medizintechnik AG, technotrans SE, VITA 34 AG, Stratec SE, SynBiotic SE and Nynomic AG.
The bottom 10 Biotechnology companies in Germany by Free Cash Flow are CureVac N.V., Evotec SE, Affimed N.V., Atai Life Sciences N.V., InflaRx N.V., Biotest Aktiengesellschaft, Heidelberg Pharma AG, Formycon AG, Vivoryon Therapeutics N.V. and Mainz Biomed B.V..